ClinConnect ClinConnect Logo
Search / Trial NCT06159543

The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes

Launched by LOMA LINDA UNIVERSITY · Nov 28, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how eating fresh mango affects health in people with prediabetes. Specifically, researchers want to learn if eating 1.5 cups of mango each day for 12 weeks can improve blood sugar levels, reduce insulin resistance (how well the body responds to insulin), lower bad cholesterol, and decrease inflammation in the body. They will compare the results of participants while they are eating mango to a period when they do not eat any mango to see if there are any changes in these health markers.

To participate, individuals should have a specific range of blood sugar levels (indicating prediabetes) and carry extra weight around their waist. However, those with certain health conditions, allergies to mango or latex, or who smoke or drink heavily are not eligible. Participants will need to attend several appointments over the study period for health checks and blood tests. This study could help us understand whether adding mango to the diet can be a tasty way to support better health for people at risk of diabetes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • HgbA1c of 5.7 to 6.4% indicative of prediabetes
  • Abdominal obesity as defined as a waist circumference \>102 cm for men or \>88 cm for women
  • Exclusion Criteria:
  • Self-reported chronic disease history (diabetes, heart disease, cancer, kidney disease, inflammatory bowel disease, etc.)
  • Pacemaker
  • Mango allergies
  • Latex allergies (cross-reactive with mango)
  • Smoking, use of tobacco, or high alcohol intake (\>2 drinks/day for men or \>1 drink per day for women)
  • Recent significant weight loss (\>5% within 6 months of study enrollment)
  • BMI \>35 kg/m\^2
  • Pregnancy or lactation
  • Use of medication and/or supplements affecting glycemic indicators or lipids
  • Habitual mango intake of \>3 servings per week and/or habitual fruit intake of \>2 servings per day
  • Not able to read and/or communicate in English

About Loma Linda University

Loma Linda University is a prominent academic institution dedicated to advancing health and wellness through innovative research and education. As a sponsor of clinical trials, Loma Linda University leverages its extensive medical and scientific expertise to conduct rigorous studies aimed at improving patient outcomes and public health. With a commitment to ethical practices and patient safety, the university collaborates with a diverse network of healthcare professionals and researchers to explore novel therapeutic interventions and enhance clinical knowledge across various medical disciplines. Through its clinical trials, Loma Linda University seeks to contribute valuable insights to the medical community and foster advancements in healthcare delivery.

Locations

Loma Linda, California, United States

Patients applied

0 patients applied

Trial Officials

Celine Heskey, DrPH

Principal Investigator

Loma Linda University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported